ArticleFrontiers in oncology2024
Ceftazidime/avibactam combined with colistimethate sodium successfully cures carbapenem-resistant
Minglu Yuan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it